Turning The Spotlight On The FDA – Why Kratom Is Still A Target
Last week, Hon. Aumua Amata Coleman Radewagen of American Samoa presented a Washington Times article in the House of Representatives. This article, “An Excuse For Crushing Kratom: The FDA’s Undue Scrutiny Is Unscientific,” highlights the inappropriate and unnecessary targeting of kratom by the FDA. One of the many arguments in support of kratom is the …
Turning The Spotlight On The FDA – Why Kratom Is Still A Target Read More »